30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status
Authors
Keywords
Spexin, Obesity, Type 2 diabetes, Liver
Journal
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 536, Issue -, Pages 111420
Publisher
Elsevier BV
Online
2021-08-09
DOI
10.1016/j.mce.2021.111420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short-term administration of spexin in rats reduces obesity by affecting lipolysis and lipogenesis: An in vivo and in vitro study
- (2020) Ewa Pruszynska-Oszmalek et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Favorable Changes in Fasting Glucose in a 6-month Self-Monitored Lifestyle Modification Programme Inversely Affects Spexin Levels in Females with Prediabetes
- (2019) Nasser M. Al-Daghri et al. Scientific Reports
- Different Spexin level in Obese vs Normal Weight Children and Its Relationship with Obesity Related Risk Factors
- (2019) Maryam Behrooz et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Circulating spexin levels are influenced by the presence or absence of gestational diabetes
- (2018) Nasser M. Al-Daghri et al. CYTOKINE
- The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes
- (2018) Sofie Hædersdal et al. MAYO CLINIC PROCEEDINGS
- Spexin Modulates Functions of Rat Endocrine Pancreatic Cells
- (2018) Maciej Sassek et al. PANCREAS
- Associations of Spexin and cardiometabolic parameters among women with and without gestational diabetes mellitus
- (2018) Nasser M. Al-Daghri et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice
- (2018) Qun Du et al. Frontiers in Physiology
- Spexin: A novel regulator of adipogenesis and fat tissue metabolism
- (2018) Pawel A. Kolodziejski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Decreased Spexin Levels in Patients with Type 1 and Type 2 Diabetes
- (2018) Anara Karaca et al. MEDICAL PRINCIPLES AND PRACTICE
- Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes
- (2017) Chi Ma et al. FEBS Journal
- Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
- (2016) Amy K. Rines et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin
- (2016) Jasmine Ge et al. SEMINARS IN LIVER DISEASE
- RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES
- (2015) Kuppan Gokulakrishnan et al. Endocrine Practice
- Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes
- (2015) Liping Gu et al. PEPTIDES
- Coevolution of the Spexin/Galanin/Kisspeptin Family: Spexin Activates Galanin Receptor Type II and III
- (2014) Dong-Kyu Kim et al. ENDOCRINOLOGY
- Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity
- (2014) José L. Walewski et al. Obesity
- Goldfish spexin: solution structure and novel function as a satiety factor in feeding control
- (2013) Matthew K. H. Wong et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes
- (2013) Axel Vater et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel neuropeptide in suppressing luteinizing hormone release in goldfish, Carassius auratus
- (2013) Yun Liu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
- (2012) Hae-Ki Min et al. Cell Metabolism
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
- Secondary causes of nonalcoholic fatty liver disease
- (2011) Jacob M. Kneeman et al. Therapeutic Advances in Gastroenterology
- Spexin Expression in Normal Rat Tissues
- (2010) Andrea Porzionato et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
- (2010) Kanji Yamaguchi et al. LABORATORY INVESTIGATION
- The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
- (2009) Ming Zhang et al. Experimental Diabetes Research
- Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses
- (2009) M. Judith Radin et al. VETERINARY CLINICAL PATHOLOGY
- Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
- (2008) Anna Wieckowska et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats
- (2008) J. Cacho et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started